Biotia raises $9M in funding to enhance diagnostics in women's health and expand into orthopedic diagnostics.
PRIVATEOct 01, 2026
Amount Raised
$9 Million
Round Type
Venture
New YorkBiotechnologyHealth CareArtificial IntelligenceHealth Diagnostics
Investors
Dr. Clive FieldsTim BarryRed Bear VenturesRed Bear AngelsLeawood Venture CapitalEgb CapitalI Lab AngelsContinuum Health VenturesCloquet Capital PartnersDigitalDx VenturesConvergent Ventures
Description
Biotia, based in NYC, raised $9M in financing from multiple backers including Convergent Ventures and DigitalDx Ventures. The funds will be used to launch additional diagnostics and pursue reimbursement efforts. Biotia focuses on infectious disease diagnostics using AI and clinical metagenomics. They operate a CLIA-certified laboratory in NYC, offering testing across all 50 U.S
Company Information
Company
Biotia
Location
New York, United States
About
Biotia is a health tech company located in New York, NY, that leverages sequencing-based technology and proprietary AI-powered software to rapidly and accurately identify microorganisms and antimicrobial resistance. Their mission is to fight infectious diseases by deploying the leading reference library of microbes worldwide. Biotia, a spinout company of Jacobs Technion-Cornell Institute at Cornell Tech, has a New York State CLIA lab for infectious disease diagnostics testing affiliated with SUNY Downstate Health Sciences University.
Connect on Twitter | Facebook | LinkedIn
Fundz sees it the moment Biotia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.